Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Advanced Cancer · Advanced Solid Tumors · TCRT

Alaunos Therapeutics

Alaunos Therapeutics trial registry — 38 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
8030 El Rio St, Houston, Texas 77054, US HQ
10 Employees
Public company Type
TCRT · NYSE Ticker
Company details
Status
Public
HQ
8030 El Rio St, Houston, Texas 77054, US
Employees
10
Programs
34
Drugs
12
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Trials

Alaunos Therapeutics clinical trials

Registry index of 38 ClinicalTrials.gov studies linked to Alaunos Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Alaunos Therapeutics trial registry — 38 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Alaunos Therapeutics.

  1. Palifosfamide Tris and Doxorubicin — Phase 2

    Clinical update

  2. palifosfamide — Phase 2

    Clinical update

  3. oral palifosfamide tris — Phase 1

    Clinical update

  4. doxorubicin in combination with palifosfamide-tris — Phase 3

    Clinical update

  5. Darinaparsin — Phase 2

    Clinical update

  6. INXN-2001 — Phase 2

    Clinical update

  7. INXN-1001 — Phase 1

    Clinical update

  8. ZIO-201-T and doxorubicin — Phase 1

    Clinical update

Trial registry

38 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.